Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 62
Titolo Data di pubblicazione Autore(i) File
Preclinical efficacy of carfilzomib in BRAF-mutant colorectal cancer models 2024 Maione, Federica; Oddo, Daniele; Galvagno, Federica; Falcomatà, Chiara; Pandini, Marta; Macagno, Marco; Pessei, Valeria; Barault, Ludovic; Gigliotti, Chiara; Mira, Alessia; Corti, Giorgio; Lamba, Simona; Riganti, Chiara; Castella, Barbara; Massaia, Massimo; Rad, Roland; Saur, Dieter; Bardelli, Alberto; Di Nicolantonio, Federica
Exploring circular MET RNA as a potential biomarker in tumors exhibiting high MET activity 2023 Bersani, Francesca; Picca, Francesca; Morena, Deborah; Righi, Luisella; Napoli, Francesca; Russo, Mariangela; Oddo, Daniele; Rospo, Giuseppe; Negrino, Carola; Castella, Barbara; Volante, Marco; Listì, Angela; Zambelli, Vanessa; Benso, Federica; Tabbò, Fabrizio; Bironzo, Paolo; Monteleone, Emanuele; Poli, Valeria; Pietrantonio, Filippo; Di Nicolantonio, Federica; Bardelli, Alberto; Ponzetto, Carola; Novello, Silvia; Scagliotti, Giorgio V; Taulli, Riccardo
Daratumumab with or without chemotherapy in relapsed and refractory acute lymphoblastic leukemia. A retrospective observational Campus Acute Lymphoblastic Leukemia study 2022 Cerrano, Marco; Bonifacio, Massimiliano; Olivi, Matteo; Curti, Antonio; Malagola, Michele; Dargenio, Michelina; Scattolin, Anna Maria; Papayannidis, Cristina; Forghieri, Fabio; Gurrieri, Carmela; Tanasi, Ilaria; Zappasodi, Patrizia; La Starza, Roberta; Fracchiolla, Nicola Stefano; Chiusolo, Patrizia; Giaccone, Luisa; Del Principe, Maria Ilaria; Giglio, Fabio; Defina, Marzia; Favre, Claudio; Rizzari, Carmelo; Castella, Barbara; Pizzolo, Giovanni; Ferrara, Felicetto; Chiaretti, Sabina; Foà, Robin
Molecular dynamics of targeting CD38 in multiple myeloma 2021 Malavasi F.; Faini A.C.; Morandi F.; Castella B.; Incarnato D.; Oliviero S.; Horenstein A.L.; Massaia M.; van de Donk N.W.C.J.; Richardson P.G.
Immunomodulatory and clinical effects of daratumumab in T-cell acute lymphoblastic leukaemia 2020 Cerrano M.; Castella B.; Lia G.; Olivi M.; Faraci D.G.; Butera S.; Martella F.; Scaldaferri M.; Cattel F.; Boccadoro M.; Massaia M.; Ferrero D.; Bruno B.; Giaccone L.
Mitochondrial metabolism: Inducer or therapeutic target in tumor immune-resistance? 2020 Kopecka J, Gazzano E, Castella B, Salaroglio IC, Mungo E, Massaia M, Riganti C
Metabolic approaches to rescue antitumor Vγ9Vδ2 T-cell functions in myeloma 2020 Castella, Barbara; Riganti, Chiara; Massaia, Massimo
CyTOF®: A New Tool to Decipher the Immunomodulatory Activity of Daratumumab 2019 Castella B, Mina R, Gay F
Ectonucleotidase expression on human amnion epithelial cells: Adenosinergic pathways and dichotomic effects on immune effector cell populations 2019 Morandi, Fabio*; Horenstein, Alberto L.; Quarona, Valeria; Faini, Angelo Corso; Castella, Barbara; Srinivasan, Raghuraman C.; Strom, Stephen C.; Malavasi, Fabio; Gramignoli, Roberto
ABCA1, apoA-I, and BTN3A1: A Legitimate ménage à trois in dendritic cells 2018 Riganti, Chiara; Castella, Barbara; Massaia, Massimo
Vγ9Vδ2 T cells as strategic weapons to improve the potency of immune checkpoint blockade and immune interventions in human myeloma 2018 Barbara Castella, Assunta Melaccio, Myriam Foglietta, Chiara Riganti, Massimo Massaia
Vγ9Vδ2 T Cells in the Bone Marrow of Myeloma Patients: A Paradigm of Microenvironment-Induced Immune Suppression 2018 Barbara Castella, Myriam Foglietta, Chiara Riganti, Massimo Massaia
Microvesicles released from multiple myeloma cells are equipped with ectoenzymes belonging to canonical and non-canonical adenosinergic pathways and produce adenosine from ATP and NAD. 2018 Morandi F, Marimpietri D, Horenstein AL, Bolzoni M, Toscani D, Costa F, Castella B, Faini AC, Massaia M, Pistoia V, Giuliani N, Malavasi F
Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer 2018 Salaroglio, Iris C; Gazzano, Elena; Abdullrahman, Ahmad; Mungo, Eleonora; Castella, Barbara; Abd-Elrahman, Gamal Eldein Fathy Abd-Ellatef; Massaia, Massimo; Donadelli, Massimo; Rubinstein, Menachem; Riganti, Chiara; Kopecka, Joanna
The ATP-binding cassette transporter A1 regulates phosphoantigen release and Vγ9Vδ2 T cell activation by dendritic cells 2017 Castella, Barbara; Kopecka, Joanna; Sciancalepore, Patrizia; Mandili, Giorgia; Foglietta, Myriam; Mitro, Nico; Caruso, Donatella; Novelli, Francesco; Riganti, Chiara; Massaia, Massimo
TARGETING HIF-1A AND ITS REGULATORY PATHWAYS AS A STRATEGY TO HAMPER LEUKEMIA-MICROENVIRONMENT INTERACTIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA 2017 Vitale, C; Griggio, V; Todaro, M; Riganti, C; Salaroglio, IC; Salvetti, C; Rigoni, M; Foglietta, M; Castella, B; Boccadoro, M; Massaia, M; Coscia, M
TARGETING HIF-1 AND ITS REGULATORY PATHWAYS AS A STRATEGY TO HAMPER TUMOR-MICROENVIRONMENT INTERACTIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA 2017 Vitale, C; Griggio, V; Todaro, M; Riganti, C; Salaroglio, IC; Salvetti, C; Rigoni, M; Foglietta, M; Castella, B; Boccadoro, M; Massaia, M; Coscia, M
Humoral immune responses toward tumor-derived antigens in previously untreated patients with chronic lymphocytic leukemia 2016 Griggio, Valentina; Mandili, Giorgia; Vitale, Candida; Capello, Michela; Macor, Paolo; Serra, Sara; Castella, Barbara; Peola, Silvia; Foglietta, Myriam; Drandi, Daniela; Omedé, Paola; Sblattero, Daniele; Cappello, Paola; Chiarle, Roberto; Deaglio, Silvia; Boccadoro, Mario; Novelli, Francesco; Massaia, Massimo; Coscia, Marta
The CXCR4 downstream signaling pathways in chronic lymphocytic leukemia: a target to reverse microenvironment protection 2016 Vitale C, Griggio V, Todaro M, Riganti C, Salaroglio IC, Salvetti C, Rigoni M, Foglietta M, Castella B, Boccadoro M, Massaia M, Coscia M
TARGETING THE CXCR4 DOWNSTREAM SIGNALLING PATHWAYS TO REVERSE MICROENVIRONMENT PROTECTION IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS 2016 Vitale, C; Griggio, V; Todaro, M; Riganti, C; Salaroglio, IC; Salvetti, C; Rigoni, M; Foglietta, M; Castella, B; Boccadoro, M; Massaia, M; Coscia, M
Mostrati risultati da 1 a 20 di 62
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile